Candel Therapeutics’ Board Goes All‑In: Eight Directors Grab 32,000 Zero‑Priced Options as Share Price Surges and Social Media Buzz Explodes
Insider buys 32k Candel Therapeutics options for zero‑price, signaling board confidence in upcoming clinical milestones and potential rally.
3 minutes to read